Opening book details…
About this Medicine article
Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors by Zhou, Yue; Wang, Bo; Qu, Jinghan; Yu, Fan; Zhao, Yang; Li, Shuyan; Zeng, Ya; Yang, Xi; Chu, Li; Chu, Xiao; Li, Yida; Zou, Liqing; Guo, Tiantian; Ye, Luxi; Liang, Fei; Wang, Shengping; Liu, Quan; Ni, Jianjiao; Zhu, Zhengfei is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Zhou, Yue; Wang, Bo; Qu, Jinghan; Yu, Fan; Zhao, Yang; Li, Shuyan; Zeng, Ya; Yang, Xi; Chu, Li; Chu, Xiao; Li, Yida; Zou, Liqing; Guo, Tiantian; Ye, Luxi; Liang, Fei; Wang, Shengping; Liu, Quan; Ni, Jianjiao; Zhu, Zhengfei
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 2020
- Field
- Medicine (Health Sciences)